Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
580 | nsp12:A580-; | CL-3d;CL-3e; |
581 | nsp12:A581V; | CL-3e; |
585 | nsp12:A585T; | CL-3c;CL-3d; |
625 | nsp12:A625S; | CL-3b;CL-3c;CL-3e; |
625 | nsp12:A625T; | CL-1a_3d; |
634 | nsp12:A634S; | CL-3d; |
639 | nsp12:A639-; | CL-1b; |
639 | nsp12:A639S; | CL-3d; |
639 | nsp12:A639V; | CL-3b;CL-3f; |
656 | nsp12:A656T; | CL-1a_2;CL-2;CL-3d; |
685 | nsp12:A685-; | CL-3b; |
685 | nsp12:A685S; | CL-3d; |
688 | nsp12:A688S; | CL-3d; |
699 | nsp12:A699S; | CL-1b;CL-3b;CL-3e; |
702 | nsp12:A702-; | CL-3d; |
702 | nsp12:A702S; | CL-3e; |
706 | nsp12:A706-; | CL-3b; |
706 | nsp12:A706S; | CL-3f; |
706 | nsp12:A706T; | CL-3a;CL-3d; |
706 | nsp12:A706V; | CL-3d; |
716 | nsp12:A716-; | CL-1a;CL-3f; |
716 | nsp12:A716V; | CL-3b; |
747 | nsp12:A747T; | CL-3c; |
762 | nsp12:A762T; | CL-3d; |
771 | nsp12:A771-; | CL-3b; |
771 | nsp12:A771S; | CL-3e; |
771 | nsp12:A771V; | CL-1a_3c;CL-3c;CL-3d; |
777 | nsp12:A777-; | CL-3d; |
777 | nsp12:A777S; | CL-3e;CL-3f; |
797 | nsp12:A797-; | CL-1b;CL-3c; |
840 | nsp12:A840-; | CL-3b; |
840 | nsp12:A840S; | CL-3e; |
866 | nsp12:A866-; | CL-3b; |
878 | nsp12:A878S; | CL-3c;CL-3e;CL-3f; |
878 | nsp12:A878T; | CL-1a; |
923 | nsp12:A923-; | CL-3c; |
923 | nsp12:A923V; | CL-3f; |
95 | nsp12:A95T; | CL-5; |
97 | nsp12:A97-; | CL-1a;CL-1a_3e;CL-3b; |
12 | nsp12:C12-; | CL-3f; |
12 | nsp12:C12F; | CL-3b; |
12 | nsp12:C12R; | CL-3c;CL-3e; |
151 | nsp12:C151Y; | CL-3c; |
193 | nsp12:C193S; | CL-3b; |
22 | nsp12:C22F; | CL-3e; |
22 | nsp12:C22Y; | CL-3e; |
298 | nsp12:C298S; | CL-3b; |
306 | nsp12:C306R; | CL-3e; |
464 | nsp12:C464-; | CL-3e; |
464 | nsp12:C464F; | CL-3b;CL-3c;CL-3d;CL-3f; |
Page 156 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com